Taylor Daphne
SEC CIK 1393549 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | SVP, CFO | 638 | — | — | 8 | 2023-03-04 | 2026-08-06 |
Most active insiders at APVO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grant Grady III | Dir | $20.1K | — |
| 2 | Kwon SoYoung | SVP, GC, BD, Corp Affairs | — | — |
| 3 | Huebner Dirk | SVP, CMO | — | — |
| 4 | Kunz Barbara Lopez | Dir | — | — |
| 5 | Lamothe Jeffrey G. | Pres, CEO, Dir | — | — |
| 6 | Niederhuber John | Dir | — | — |
| 7 | White Marvin L | Executive COB, Dir | — | — |
| 8 | Taylor Daphne | SVP, CFO | — | — |
| 9 | Abdun-Nabi Daniel | Dir | — | — |
| 10 | Harsanyi Zsolt | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 21:37 | 2026-08-06 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +638 | 638 | New | — |
| D | 2025-07-21 | 2025-07-17 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +3 | 3 | New | — |
| DM | 2025-03-04 | 2025-03-02+ | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +3 | 18 | +20% | — |
| D | 2024-08-09 | 2024-08-08 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +158 | 576 | +38% | — |
| DM | 2024-03-05 | 2024-03-02+ | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +5,251 | 18.4K | +40% | — |
| D | 2024-01-30 | 2024-01-29 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +792 | 13.2K | +6% | — |
| D | 2023-08-10 | 2023-08-08 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +6,945 | 12.4K | +128% | — |
| D | 2023-03-07 | 2023-03-04 | APVO | Aptevo Therapeutics Inc. | Taylor Daphne | SVP, CFO | M - OptEx | — | +1,583 | 5,423 | +41% | — |
Purchase Sale Sale after option exercise All abbreviations